PPARα/γ/δ agonist 1

• Description:

  PPARα/γ/δ agonist 1 (Compound 2) is a potent PPARα/γ/δ agonist, with an IC50 of 70 nM for PPARγ. PPARα/γ/δ agonist 1 can be used for the research of type 2 diabetes[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  PPAR

• Related Pathways:

  Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Field of Research:

  Metabolic Disease

• Smiles:

  O=C(CN1C=CC2=C1C=CC(OCCCOC3=C(CCC)C4=CC=C(C(C5=CC=CC=C5)=O)C=C4C=C3)=C2)O

• Molecular Formula:

  C33H31NO5

• Molecular Weight:

  521.60

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Mahindroo N, et al. Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists. J Med Chem. 2006 Oct 19;49 (21) :6421-4.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [853652-40-1]